X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8288) 8288
Publication (734) 734
Newsletter (182) 182
Book Review (145) 145
Book Chapter (58) 58
Magazine Article (48) 48
Newspaper Article (25) 25
Book / eBook (16) 16
Dissertation (12) 12
Reference (5) 5
Trade Publication Article (5) 5
Transcript (4) 4
Report (2) 2
Web Resource (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6350) 6350
female (4476) 4476
folic acid (3720) 3720
index medicus (3715) 3715
male (2806) 2806
adult (2309) 2309
pregnancy (2264) 2264
middle aged (1696) 1696
folic-acid (1556) 1556
risk factors (1472) 1472
folic acid - administration & dosage (1431) 1431
animals (1335) 1335
folate (1316) 1316
homocysteine (1308) 1308
aged (1272) 1272
dietary supplements (1245) 1245
folic acid - blood (1138) 1138
nutrition & dietetics (1089) 1089
folic acid - therapeutic use (1077) 1077
health aspects (978) 978
vitamin b (956) 956
homocysteine - blood (863) 863
research (804) 804
diet (776) 776
neural-tube defects (774) 774
risk (772) 772
cancer (738) 738
analysis (725) 725
adolescent (702) 702
nutrition (701) 701
prevention (687) 687
folic acid - metabolism (681) 681
pharmacology & pharmacy (580) 580
supplementation (578) 578
women (576) 576
folic acid - adverse effects (575) 575
physiological aspects (561) 561
infant, newborn (544) 544
child (535) 535
young adult (529) 529
oncology (525) 525
vitamin b 12 - blood (524) 524
pregnant women (509) 509
medicine, general & internal (500) 500
metabolism (483) 483
dna methylation (479) 479
methotrexate (477) 477
article (448) 448
mice (444) 444
children (440) 440
public, environmental & occupational health (435) 435
care and treatment (428) 428
treatment outcome (423) 423
vitamin b12 (423) 423
rats (422) 422
prospective studies (420) 420
plasma homocysteine (418) 418
prevalence (416) 416
methylenetetrahydrofolate reductase (414) 414
folic-acid supplementation (412) 412
vitamins (400) 400
case-control studies (399) 399
infant (392) 392
folic acid - pharmacology (387) 387
methotrexate - adverse effects (381) 381
public health (377) 377
oxidative stress (371) 371
nutritional status (370) 370
anemia (369) 369
folic acid antagonists - adverse effects (364) 364
medicine (361) 361
child, preschool (360) 360
hyperhomocysteinemia (355) 355
medicine & public health (354) 354
studies (351) 351
obstetrics & gynecology (350) 350
anticonvulsants - adverse effects (348) 348
cardiovascular-disease (344) 344
research article (342) 342
methylation (337) 337
disease (336) 336
pediatrics (330) 330
iron (324) 324
mortality (324) 324
neural tube defects - prevention & control (322) 322
acids (314) 314
therapy (304) 304
aged, 80 and over (303) 303
dose-response relationship, drug (303) 303
methylenetetrahydrofolate reductase - genetics (303) 303
epidemiology (301) 301
vascular-disease (300) 300
drugs (299) 299
toxicity (299) 299
birth defects (298) 298
chemotherapy (297) 297
folic acid deficiency - complications (295) 295
time factors (291) 291
womens health (290) 290
folic acid antagonists - therapeutic use (289) 289
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8197) 8197
German (122) 122
French (68) 68
Spanish (55) 55
Japanese (31) 31
Russian (23) 23
Italian (22) 22
Dutch (19) 19
Polish (18) 18
Norwegian (13) 13
Chinese (12) 12
Swedish (11) 11
Danish (8) 8
Portuguese (6) 6
Bulgarian (4) 4
Hebrew (4) 4
Hungarian (4) 4
Turkish (3) 3
Finnish (2) 2
Romanian (2) 2
Czech (1) 1
Icelandic (1) 1
Korean (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Neurology, The, ISSN 1474-4422, 2011, Volume 10, Issue 7, pp. 609 - 617
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9871, pp. 1029 - 1036
Journal Article
Epilepsia, ISSN 0013-9580, 01/2012, Volume 53, Issue 1, pp. 120 - 128
Summary Purpose:  Long‐term therapy with antiepileptic drugs (AEDs) has been associated with metabolic consequences that lead to an increase in risk of... 
Antiepileptic drugs | Monotherapy | Vascular risk factors | Atherosclerosis | Intima media thickness | INTIMA-MEDIA THICKNESS | MORTALITY | HOMOCYSTEINE | MYOCARDIAL-INFARCTION | CARBAMAZEPINE | FOLIC-ACID | CLINICAL NEUROLOGY | SODIUM VALPROATE | URIC-ACID | CARDIOVASCULAR RISK | EPILEPTIC CHILDREN | Follow-Up Studies | Humans | Middle Aged | Anticonvulsants - administration & dosage | Male | Young Adult | Anticonvulsants - adverse effects | Carbamazepine - administration & dosage | Time Factors | Adult | Female | Uric Acid - blood | Valproic Acid - adverse effects | Cross-Sectional Studies | Atherosclerosis - chemically induced | Risk Factors | Homocysteine - blood | Phenytoin - administration & dosage | Blood Glucose - drug effects | Carbamazepine - adverse effects | Valproic Acid - administration & dosage | Phenytoin - adverse effects | Carotid Artery, Common - drug effects | Adolescent | Folic Acid - blood | Carotid Artery, Common - pathology | Epilepsy - drug therapy | Aged | Medical colleges | Anticonvulsants | Blood sugar | Epilepsy | Uric acid | Homocysteine | Risk factors | Cholesterol | Folic acid | Enzymes | Acids | Drugs | C-reactive protein | Fasting | lamotrigine | thiobarbituric acid | Antiepileptic agents | Metabolism | Valproic acid | Carbamazepine | Body mass index | Arteriosclerosis | Carotid artery | Phenytoin | Sugar | Long-term effects
Journal Article
The Lancet, ISSN 0140-6736, 2006, Volume 367, Issue 9505, pp. 133 - 143
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 35, pp. 4400 - 4406
Journal Article
Annual Review of Nutrition, ISSN 0199-9885, 7/2016, Volume 36, Issue 1, pp. 211 - 239
Moderately elevated plasma total homocysteine (tHcy) is a strong modifiable risk factor for vascular dementia and Alzheimer's disease. Prospectively, elevated... 
clinical trial | dementia | folate | cobalamin (vitamin B12) | cognition | Alzheimer's disease | PLASMA TOTAL HOMOCYSTEINE | BRAIN ATROPHY | ALZHEIMERS-DISEASE | FATTY-ACID-METABOLISM | RANDOMIZED CONTROLLED-TRIAL | NUTRITION & DIETETICS | SMALL-VESSEL DISEASE | MEDIAL TEMPORAL-LOBE | WHITE-MATTER HYPERINTENSITIES | PLACEBO-CONTROLLED TRIAL | TRANSIENT CEREBRAL-ISCHEMIA | Hyperhomocysteinemia - epidemiology | Folic Acid - therapeutic use | Folic Acid - adverse effects | Neurodegenerative Diseases - etiology | Nootropic Agents - metabolism | Humans | Neurodegenerative Diseases - prevention & control | Hyperhomocysteinemia - metabolism | Vitamin B 12 - adverse effects | Homocysteine - metabolism | Vitamin B 12 - therapeutic use | Cognitive Dysfunction - prevention & control | Hyperhomocysteinemia - physiopathology | Cognition Disorders - prevention & control | Cognition Disorders - etiology | Cognitive Dysfunction - epidemiology | Aging | Nutritional Status | Dietary Supplements - adverse effects | Vitamin B 6 - metabolism | Risk Factors | Homocysteine - blood | Nootropic Agents - therapeutic use | Cerebrovascular Circulation | Cognitive Dysfunction - etiology | Evidence-Based Medicine | Nootropic Agents - adverse effects | Animals | Neurodegenerative Diseases - physiopathology | Vitamin B 6 - adverse effects | Vitamin B 6 - therapeutic use | Biomarkers | Folic Acid - metabolism | Hyperhomocysteinemia - diet therapy | Cognition Disorders - epidemiology | Neurodegenerative Diseases - epidemiology | Vitamin B 12 - metabolism | Practice Guidelines as Topic | Physiological aspects | Homocysteine | Health aspects | Dementia
Journal Article